Advisory Services Network LLC cut its position in shares of Hologic, Inc. (NASDAQ:HOLX) by 49.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,808 shares of the medical equipment provider’s stock after selling 1,775 shares during the quarter. Advisory Services Network LLC’s holdings in Hologic were worth $88,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently made changes to their positions in HOLX. Contravisory Investment Management Inc. acquired a new position in shares of Hologic during the first quarter valued at $373,000. Stephens Investment Management Group LLC increased its holdings in shares of Hologic by 0.6% during the first quarter. Stephens Investment Management Group LLC now owns 693,183 shares of the medical equipment provider’s stock valued at $33,550,000 after purchasing an additional 4,176 shares during the period. Toronto Dominion Bank increased its holdings in shares of Hologic by 17.5% during the first quarter. Toronto Dominion Bank now owns 192,929 shares of the medical equipment provider’s stock valued at $9,336,000 after purchasing an additional 28,706 shares during the period. Geode Capital Management LLC increased its holdings in shares of Hologic by 5.3% during the fourth quarter. Geode Capital Management LLC now owns 3,805,329 shares of the medical equipment provider’s stock valued at $156,146,000 after purchasing an additional 190,788 shares during the period. Finally, Janney Montgomery Scott LLC increased its holdings in shares of Hologic by 21.7% during the first quarter. Janney Montgomery Scott LLC now owns 7,166 shares of the medical equipment provider’s stock valued at $347,000 after purchasing an additional 1,276 shares during the period. Hedge funds and other institutional investors own 96.38% of the company’s stock.
A number of research firms recently issued reports on HOLX. ValuEngine raised China Southern Airlines from a “sell” rating to a “hold” rating in a report on Tuesday, June 11th. BidaskClub lowered Weyco Group from a “sell” rating to a “strong sell” rating in a report on Saturday, July 13th. Zacks Investment Research raised Hudson Technologies from a “sell” rating to a “hold” rating in a research note on Wednesday, May 29th. BTIG Research lifted their price target on Yum! Brands to $114.00 and gave the stock a “buy” rating in a research note on Thursday, May 2nd. Finally, Needham & Company LLC dropped their price target on to $10.00 and set a “buy” rating on the stock in a research note on Wednesday, July 10th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and six have issued a buy rating to the company’s stock. Hologic presently has a consensus rating of “Hold” and an average price target of $45.02.
Hologic (NASDAQ:HOLX) last issued its quarterly earnings data on Wednesday, May 1st. The medical equipment provider reported $0.58 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.57 by $0.01. The business had revenue of $818.40 million for the quarter, compared to the consensus estimate of $806.99 million. Hologic had a positive return on equity of 26.73% and a negative net margin of 0.32%. The firm’s revenue was up 3.7% compared to the same quarter last year. During the same period last year, the business earned $0.53 EPS. As a group, sell-side analysts anticipate that Hologic, Inc. will post 2.42 earnings per share for the current year.
In other Hologic news, insider Peter J. Valenti III sold 4,545 shares of the business’s stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $44.07, for a total value of $200,298.15. The transaction was disclosed in a document filed with the SEC, which is available at this link. 0.90% of the stock is owned by insiders.
Hologic, Inc, a medical technology company, develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. It operates in five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health.
Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.